Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Literature DB >> 19716939

American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Sarah Temin¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2009 PMID： 19716939 PMCID： PMC4119170 DOI： 10.1016/j.ygyno.2009.06.006

Source DB: PubMed Journal: Gynecol Oncol ISSN： 0090-8258 Impact factor: 5.482

× No keyword cloud information.

1 in total

1. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Authors: Kala Visvanathan; Rowan T Chlebowski; Patricia Hurley; Nananda F Col; Mary Ropka; Deborah Collyar; Monica Morrow; Carolyn Runowicz; Kathleen I Pritchard; Karen Hagerty; Banu Arun; Judy Garber; Victor G Vogel; James L Wade; Powel Brown; Jack Cuzick; Barnett S Kramer; Scott M Lippman
Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544

1 in total

8 in total

1. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Authors: Laura L Reimers; Parijatham S Sivasubramanian; Dawn Hershman; Mary Beth Terry; Heather Greenlee; Julie Campbell; Kevin Kalinsky; Matthew Maurer; Ramona Jayasena; Rossy Sandoval; Maria Alvarez; Katherine D Crew
Journal: Breast J Date: 2015-04-16 Impact factor: 2.431

7. Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis.

Authors: Ulrika Islander; Caroline Jochems; Alexandra Stubelius; Annica Andersson; Marie K Lagerquist; Claes Ohlsson; Hans Carlsten
Journal: Arthritis Res Ther Date: 2011-06-20 Impact factor: 5.156

8. Innovative oral treatments of uterine leiomyoma.

Authors: Mohamed Sabry; Ayman Al-Hendy
Journal: Obstet Gynecol Int Date: 2012-02-16

8 in total

American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

1. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

1. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Review 2. Vaccine prevention of cancer: can endogenous antigens be targeted?

Review 3. Medical treatment of uterine leiomyoma.

4. The risk of developing invasive breast cancer in Hispanic women : a look across Hispanic subgroups.

5. Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer.

6. Osteoporosis care in the United States after declines in reimbursements for DXA.

7. Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis.

8. Innovative oral treatments of uterine leiomyoma.